Evolvence invests Rs 25 crore in Anjan Drugs

10th Jun 2009
  • +0
Share on
close
  • +0
Share on
close
Share on
close

VCCircle reports that Evolvence India Life Sciences Fund (EILSF) has invested Rs 25 crore in Chennai-based pharmaceutical company, Anjan Drugs Pvt. Ltd. With $150 million worth assets under management (AUM) the fund provides growth capital to Indian pharmaceutical and biotechnology companies. Last the year, the fund had invested $30 million in the Hyderabad-based advanced drug delivery mechanism company, Gland Pharma. EILSF has also invested about $5 million in Bangalore-based cancer centre network, Health Care Global.


About two months back, Indian Angel Network invested $500,000 in Karmic Life Sciences, Mumbai-based oncology focused contract research organisation (CRO). Similarly, Rx HealthCare Magic, which runs a healthcare portal HealthcareMagic.com, raised Series A funding of $2.5 million from Accel India in February this year. Among other merger and acquisition deals include diagnostic chain Metropolis' acquisition of two pathlabs in northern India. Yash Birla Group acquired a majority stake in Kerala Vaidyashala, in January. Recently, Sabre Capital too set up a company called Spring Healthcare Ltd through which it plans to make investments of around Rs 250 crore in the Indian healthcare space.

Want to make your startup journey smooth? YS Education brings a comprehensive Funding Course, where you also get a chance to pitch your business plan to top investors. Click here to know more.

    • +0
    Share on
    close
    • +0
    Share on
    close
    Share on
    close